Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer

Oncogene

Volumn 29, Issue 8, 2010, Pages 1155-1166

  Ahn, B Y ^a   Trinh, D L N ^a   Zajchowski, L D ^a   Lee, B ^a   Elwi, A N ^a   Kim, S W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Apoptosis; Mitochondria; P53; Tid1; Tumor suppressor

Indexed keywords

MUTANT PROTEIN; PROTEIN P53; PROTEIN TID1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSOL; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOXIA; MITOCHONDRION; NEOPLASM; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

APOPTOSIS; CYTOSOL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENES, TUMOR SUPPRESSOR; HSP40 HEAT-SHOCK PROTEINS; HUMANS; MITOCHONDRIA; NEOPLASMS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77649190277     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.413     Document Type: Article

References (38)

1. Anderson AR, Weaver AM, Cummings PT, Quaranta V. (2006). Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127: 905-915.
2. Bissonnette N, Wasylyk B, Hunting DJ. (1997). The apoptotic and transcriptional transactivation activities of p53 can be dissociated. Biochem Cell Biol 75: 351-358.
3. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M et al. (2004). Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303: 1010-1014.
4. Chipuk JE, Green DR. (2008). How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18: 157-164.
5. Chopin V, Toillon RA, Jouy N, Le Bourhis X. (2002). Sodium butyrate induces P53-independent Fas-mediated apoptosis in MCF-7 human breast cancer cells. Br J Pharmacol 135: 79-86.
6. Cui Q, Yu JH, Wu JN, Tashiro S, Onodera S, Minami M et al. (2007). P53-mediated cell cycle arrest and apoptosis through a caspase-3-independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells. Acta Pharmacol Sin 28: 1057-1066.
7. Dumont P, Leu JI, Della III PA, George DL, Murphy M. (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33: 357-365.
8. Edwards KM, Munger K. (2004). Depletion of physiological levels of the human TID1 protein renders cancer cell lines resistant to apoptosis mediated by multiple exogenous stimuli. Oncogene 23: 8419-8431.
9. Erster S, Mihara M, Kim RH, Petrenko O, Moll UM. (2004). In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 24: 6728-6741.
10. Fridman JS, Lowe SW. (2003). Control of apoptosis by p53. Oncogene 22: 9030-9040.
11. Gomez JA, Gama V, Yoshida T, Sun W, Hayes P, Leskov K et al. (2007). Bax-inhibiting peptides derived from Ku70 and cell-penetrating pentapeptides. Biochem Soc Trans 35: 797-801.
12. Hammond EM, Giaccia AJ. (2005). The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 331: 718-725.
13. Haupt Y, Maya R, Kazaz A, Oren M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299.
14. Haupt Y, Rowan S, Shaulian E, Vousden KH, Oren M. (1995). Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev 9: 2170-2183.
15. Hinds PW, Finlay CA, Quartin RS, Baker SJ, Fearon ER, Vogelstein B et al. (1990). Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the 'hot spot' mutant phenotypes. Cell Growth Differ 1: 571-580.
16. Kim SW, Chao TH, Xiang R, Lo JF, Campbell MJ, Fearns C et al. (2004). Tid1, the human homologue of a Drosophila tumor suppressor, reduces the malignant activity of ErbB-2 in carcinoma cells. Cancer Res 64: 7732-7739.
17. Kim SW, Hayashi M, Lo JF, Fearns C, Xiang R, Lazennec G et al. (2005). Tid1 negatively regulates the migratory potential of cancer cells by inhibiting the production of interleukin-8. Cancer Res 65: 8784-8791.
18. Kim BM, Choi JY, Kim YJ, Woo HD, Chung HW. (2007). Desferroxamine (DFX) has genotoxic effects on cultured human lymphocytes and induces the p53-mediated damage response. Toxicology 229: 226-235.
19. King FW, Wawrzynow A, Hohfeld J, Zylicz M. (2001). Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53. EMBO J 20: 6297-6305.
20. Kokontis JM, Wagner AJ, O'Leary M, Liao S, Hay N. (2001). A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Oncogene 20: 659-668.
21. Leu JI, Dumont P, Hafey M, Murphy ME, George DL. (2004). Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 6: 443-450.
22. Lu B, Garrido N, Spelbrink JN, Suzuki CK. (2006). Tid1 isoforms are mitochondrial DnaJ-like chaperones with unique carboxyl termini that determine cytosolic fate. J Biol Chem 281: 13150-13158.
23. Lukashchuk N, Vousden KH. (2007). Ubiquitination and degradation of mutant p53. Mol Cell Biol 27: 8284-8295.
24. Marchenko ND, Wolff S, Erster S, Becker K, Moll UM. (2007). Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J 26: 923-934.
25. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P et al. (2003). p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11: 577-590.
26. Mooney LM, Al-Sakkaf KA, Brown BL, Dobson PR. (2002). Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells. Br J Cancer 87: 909-917.
27. Murphy ME, Leu JI, George DL. (2004). p53 moves to mitochondria: a turn on the path to apoptosis. Cell Cycle 3: 836-839.
28. Nemajerova A, Erster S, Moll UM. (2005). The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria. Cell Death Differ 12: 197-200.
29. Perfettini JL, Kroemer RT, Kroemer G. (2004). Fatal liaisons of p53 with Bax and Bak. Nat Cell Biol 6: 386-388.
30. Pietsch EC, Perchiniak E, Canutescu AA, Wang G, Dunbrack RL, Murphy ME. (2008). Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain. J Biol Chem 283: 21294-21304.
31. Puthalakath H, O-Reilly LA, Gunn P, Lee L, Kelly PN, Huntington ND et al. (2007). ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129: 1337-1349.
32. Sansome C, Zaika A, Marchenko ND, Moll UM. (2001). Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett 488: 110-115.
33. Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P, Green DR. (2000). p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem 275: 7337-7342. (Pubitemid 30146286)
34. Vogelstein B, Lane D, Levine AJ. (2000). Surfing the p53 network. Nature 408: 307-310.
35. Wang P, Yu J, Zhang L. (2007). The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage. Proc Natl Acad Sci USA 104: 4054-4059.
36. Wang LH, Okaichi K, Ihara M, Okumura Y. (1998). Sensitivity of anticancer drugs in Saos-2 cells transfected with mutant p53 varied with mutation point. Anticancer Res 18: 321-325. (Pubitemid 28174726)
37. Wolff S, Erster S, Palacios G, Moll UM. (2008). p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res 18: 733-744.
38. Wolff S, Erster S, Palacios G, Moll UM. (2008). p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severly disrupts mitochondrial membrane integrity. Cell Res 18: 733-744.